Author

Geneviève Garcin

Centre National de la Recherche ScientifiqueORCID 0000-0001-9669-7057Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Camille Chatelain· 1 shared Jan Tavernier· 1 shared Jean‐François FonteneauiD· 1 shared Joëlle S. NaderiD· 1 shared Lucas TrepsiD· 1 shared Manon Souchard· 1 shared Mar Naranjo‐GómeziD· 1 shared Mireia PelegríniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Camille Chatelain

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A novel tumor-targeted interferon-α/-β receptor 1 antagonist increases replication of oncolytic vesicular stomatitis virus in a mouse mesothelioma model

Thomas Teja Ogor, Yann Bordat, Manon Souchard, Joëlle S. Nader, Geneviève Garcin, Camille Chatelain, Virginie Dehame, Sophie Deshayes, Lucas Treps, Mar Naranjo‐Gómez, Nicolas Boisgerault, Jan Tavernier, Mireia Pelegrín, Jean‐François Fonteneau

This paper develops IFNAR1 antagonists that selectively block IFNAR signaling in tumor cells, enhancing VSV oncolytic activity in mesothelioma and melanoma models.

bioRxiv · Jun 3, 2026 · PreprintImmunology